Cargando…
Drug Mechanisms to Help in Managing Resistant Hypertension in Obesity
Obesity is a major risk factor for the development of hypertension. Because the prevalence of obesity is increasing worldwide, the prevalence of obesity hypertension is also increasing. Importantly, hypertension in obesity is commonly complicated by dyslipidemia and type 2 diabetes mellitus and henc...
Autores principales: | Jansen, Pieter M., Danser, Jan A. H., Spiering, Wilko, van den Meiracker, Anton H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910885/ https://www.ncbi.nlm.nih.gov/pubmed/20532698 http://dx.doi.org/10.1007/s11906-010-0123-5 |
Ejemplares similares
-
Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
por: Jansen, Pieter M., et al.
Publicado: (2011) -
Identifying treatment response to antihypertensives in patients with obesity-related hypertension
por: Schrover, Ilse M., et al.
Publicado: (2017) -
Baroreflex Amplification and Carotid Body Modulation for the Treatment of Resistant Hypertension
por: Groenland, Eline H., et al.
Publicado: (2020) -
Endovascular Baroreflex Amplification for Resistant Hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2018) -
EHMTI-0096. Efficacy of sumatriptan: assessment of a possible biomarker
por: Ibrahimi, K, et al.
Publicado: (2014)